Immunogenicity and SARS-CoV-2 Infection following the Fourth BNT162b2 Booster Dose among Health Care Workers

Introduction: The fourth SARS-CoV-2 vaccine dose was found to protect against infection and more importantly against severe disease and death. It was also shown that the risk of symptomatic or severe disease was related to the antibody levels after vaccination or infection, with lower protection aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Shachor-Meyouhas, Yael, Dabaja-Younis, Halima, Magid, Avi, Leiba, Ronit, Szwarcwort-Cohen, Moran, Almog, Ronit, Mekel, Michal, Weissman, Avi, Hyams, Gila, Gepstein, Vardit, Horowitz, Nethanel A., Cohen Saban, Hagar, Tarabeia, Jalal, Halberthal, Michael, Hussein, Khetam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958857/
https://www.ncbi.nlm.nih.gov/pubmed/36851161
http://dx.doi.org/10.3390/vaccines11020283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958857/
https://www.ncbi.nlm.nih.gov/pubmed/36851161
http://dx.doi.org/10.3390/vaccines11020283

Ejemplares similares